News

Under PPD’s agreement with Takeda, the submission of the new drug application for alogliptin and Actos does not trigger a milestone payment to PPD. If the new drug

The transaction is structured as a stock-for-stock exchange and in addition, Pharmacopeia stockholders will be entitled to a contingent value right (CVR). The CVR’s will entitle holders under

CardioGen-82 is said to be the only generator-based positron emission tomography (PET) perfusion agent approved by the FDA and reimbursed for the evaluation of coronary artery disease. CardioGen-82

The FDA clearance follows Syneron’s receipt in Europe of CE mark clearance for the Matrix RF. Matrix RF utilizes Syneron’s radio frequency technology to provide effective ablation and

According to Grameen Health, these multiple, independent collaborations will focus on social business models in which the businesses are self-supporting and any profits are re-invested into the system

Center for Molecular Medicine (CMM) is a joint venture between Spectrum Health, a not-for-profit health systems in Michigan, and the Van Andel Research Institute, an independent research institute

The results showed that Ophena significantly improved a broad range of clinical signs of vulvovaginal atrophy (VVA), including petechiae, pallor, friability, vaginal dryness and redness in mucosa. These

In the Phase I study in healthy volunteers, ANA598 was administered as capsules at single doses starting at 400mg. At the 2000mg dose level, it was administered during

Results showed that with Saizen therapy, levels of all biomarkers studied significantly changed between baseline and one month in both Turner syndrome (TS) and growth hormone deficiency (GHD)